DENTSPLY SIRONA grants 471,400 stock options

DENTSPLY SIRONA Inc. granted stock options to senior executive Robert Anthony Johnson, who serves as SVP and Chief Supply Chain Officer.

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. granted stock options to senior executive Robert Anthony Johnson, who serves as SVP and Chief Supply Chain Officer. The award covers 471,400 stock options, recorded as a direct beneficial holding after the transaction.

According to the terms, these options will cliff-vest on the third anniversary of the grant date, meaning none are exercisable until that date. The exercise price will be set at 110% of the closing price of DENTSPLY SIRONA common stock on the grant date, aligning the award’s value with future share performance.

Insider Trade Summary

Grant/Award: 471,400 shares

Grant/Award 1 txn

Insider Johnson Robert Anthony

Role SVP, Chief Supply Chain Office

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	471,400	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 471,400 contracts (Direct)

Footnotes (1)

1. F1. These options will cliff-vest and become exercisable on the third anniversary of the grant date, with an exercise price equal to 110% of the closing price of the Issuer's common stock as of the date of grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did DENTSPLY SIRONA (XRAY) report on this Form 4/A?

DENTSPLY SIRONA reported a grant of 471,400 stock options to executive Robert Anthony Johnson. The options are a compensation-related award and increase his direct derivative holdings in the company’s common stock.

Who received the stock option grant in DENTSPLY SIRONA (XRAY)’s latest insider filing?

The recipient is Robert Anthony Johnson, SVP and Chief Supply Chain Officer of DENTSPLY SIRONA. He is listed as the reporting person and holds the granted options as a direct ownership position following the transaction.

How many DENTSPLY SIRONA (XRAY) stock options were granted to the executive?

The filing shows a grant of 471,400 stock options to Robert Anthony Johnson. After this award, his total derivative holdings in these options are reported as 471,400, matching the granted amount.

When do the newly granted DENTSPLY SIRONA (XRAY) stock options vest?

The options are structured to cliff-vest on the third anniversary of the grant date. This means none of the options become exercisable until that single future vesting date, rather than vesting gradually over time.

What is the exercise price for the DENTSPLY SIRONA (XRAY) options granted to Robert Johnson?

The exercise price will equal 110% of the closing price of DENTSPLY SIRONA’s common stock on the grant date. This premium exercise price links potential option value to future share performance above that reference level.

Are the DENTSPLY SIRONA (XRAY) options held directly or indirectly by the reporting person?

The Form 4/A lists the ownership as direct for Robert Anthony Johnson. There are no footnotes indicating that another entity, such as a trust or LLC, holds voting or investment authority over these options.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/06/2026 - 05:23 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Johnson Robert Anthony

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28222

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Supply Chain Office

3. Date of Earliest Transaction (Month/Day/Year)
11/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
11/12/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$12.3	11/07/2025		A		471,400		11/07/2028(1)	11/07/2035	Common Stock	471,400	$0	471,400	D

Explanation of Responses:

1. These options will cliff-vest and become exercisable on the third anniversary of the grant date, with an exercise price equal to 110% of the closing price of the Issuer's common stock as of the date of grant.

	/s/ Jessica Nielsen Causey, Attorney-In-Fact for Robert Anthony Johnson	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.